BioOra brings life-changing CAR T-cell therapies closer to equal and fair access
About BioOra
Our Mission
Imagine a world where every person who needs it can access advanced, life-changing CAR T-cell therapy.
For people facing serious illness, time is precious. Everyone deserves to have access to the best cancer treatment.
That’s why BioOra and our partners are determined to help create a world where CAR T-cell therapy is accessible to everybody – wherever they live, whatever they earn regardless of background and culture.
Thanks to our relationships with the best in science, health, and innovation – our partners at The Malaghan Institute, Bridgewest Ventures and Callaghan Innovation – BioOra has developed advanced CAR T-cell manufacturing technologies and world class clinical models of care.
Together, we’re helping transform the way CAR T-cell therapies are delivered, so that access to these life-saving cancer treatments is affordable, equal, and fair.
In Partnership
Supporting our business
BioOra is proudly supported by Bridgewest Ventures NZ LP. Bridgewest Ventures is part of the Bridgewest Group, and has a long track record of successfully incubating and launching major global innovation-led companies.
Bridgewest’s deep technology experience is wide-ranging and includes drug discovery and deep research into health technology, with expertise in novel CAR T-cell platforms.
Bridgewest Ventures leverages its extensive connections, international reach, and commercialisation experience to transform innovative opportunities into world-class companies.
Working in partnership with us
The Malaghan Institute of Medical Research is New Zealand’s world-leading independent biomedical research institute with a long history of R&D in CAR T-cell therapy.
It is working in partnership with Wellington Zhaotai Therapies to trial a ‘third generation’ CAR T cell therapy in New Zealand.
This trial is for cancer patients with relapsed and refractory B-cell non-Hodgkin lymphoma. BioOra is working with the Malaghan Institute to automate the production of CAR T-cells to support clinical trials.
Supporting innovation in NZ
We are proud to be part of Callaghan Innovation’s Technology Incubator Programme.
Callaghan Innovation is New Zealand’s innovation agency. It activates innovation and helps businesses grow faster for a better New Zealand. The government agency delivers a range of innovation and R&D services to suit each stage of business growth.
Its staff – including more than 200 of New Zealand’s leading scientists and engineers – empower innovators by connecting people, opportunities, and networks and providing tailored technical solutions, skills and capability development programmes, and grants co-funding.